Weekly Roundup 15 Dec 2023 Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered …and B funding. With the funds, it aims to develop its programmable genomic integration (PGI) technology. Combining the site-specificity of CRISPR/Cas9 with enzymes that are capable of writing DNA sequences,… December 15, 2023 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 21 Nov 2019 €37.4M Invested in Azeria Therapeutics’ Cancer Treatment Program …programs in Europe. Jason Carroll, a Professor at the University of Cambridge, explained to me that “pioneer factors are special proteins that open DNA and catalyze the process of gene… November 21, 2019 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 20 Dec 2019 Freeline’s Rare Disease Gene Therapies Get €72M Series C Boost …clot could change the lives of patients. Freeline’s therapy consists of an adenoviral vector carrying DNA encoding factor IX, a protein that helps the blood to clot. The vector delivers… December 20, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Feb 2025 12 ways biotechnology makes the world more sustainable …(corn), cotton, and soy grown in the U.S. The production of GM crops involves new DNA being transferred into plant cells and, usually, the cells are then grown in tissue… February 11, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Jan 2017 The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge …Its products support personalized decisions about cancer treatment with just a blood test, bypassing biopsies, by analyzing circulating tumor DNA (ctDNA). Clinical data from its use in lung cancer patients… January 30, 2017 - 8 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
In Depth 26 Sep 2024 The radiopharmaceutical revolution: From diagnosis to treatment, oncology and beyond …body and cause single-stranded DNA breaks to disrupt the growth of the cancerous cells. However, alpha-emitting particles – like those using actinium-225 or lead-212 – emit short-range radiation, but the… September 26, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 14 Jun 2017 French Hepatitis Cure is on Track with Positive Phase I Results …and is able to interfere with HBV replication by impacting the transcriptional activity of cccDNA, which serves as a template for all viral RNAs. In addition, FXR agonists have recently… June 14, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 24 Mar 2023 Metabolism of RNA linked to leukemia …at Lund University Stem Cell Center and first author of the study. Ciesla is now a group leader at IMOL, Poland. DNA damage The authors further investigated the molecular determinants… March 24, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Jan 2024 Ten NK cell therapy companies to look out for this year …from DNA sequences so as to reprogram cells to compute decisions and respond to their cellular environments. The company aims to target multiple disease pathways with a single drug as… January 11, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 27 Oct 2023 Big pharma monopolies: major antitrust cases over the past decade …investor Carl Icahn suing the DNA giant following a proxy battle, it traces back to an acquisition deal that misfired not too long ago. When the multinational biotech had spun… October 27, 2023 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 27 Nov 2024 Charcot–Marie–Tooth disease: what’s going on in the clinical field? …contains a plasmid DNA that contains a gene that codes for a growth factor to promote neuromuscular activity. However, a recent clinical failure in another nerve disease called diabetic peripheral… November 27, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 25 Mar 2021 Covid-19 Vaccine Approvals Bring Hope and Challenges for Adenoviral Technology …dominant technology platforms for vaccinating the world against Covid-19. Adenoviruses make up a diverse family of DNA viruses that typically cause mild respiratory symptoms in humans such as the common… March 25, 2021 - 6 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email